文献速递神经肿瘤功能神经外科

立体定向放射外科治疗2型神经纤维瘤病患者的前庭神经鞘瘤:系统综述与Meta分析

Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis.
PubMed 文献 · J Neurooncol · 2022-01-18

该系统综述与Meta分析检索Ovid MEDLINE、EMBASE、Web of Science和Cochrane Reviews,纳入16项研究(589例患者、750个肿瘤),评估立体定向放射外科治疗2型神经纤维瘤病相关前庭神经鞘瘤的结局。结果显示临床肿瘤控制率达88%(95%CI 80-95%),需挽救手术者占8%(95%CI 4-13%),但治疗与既往可服务听力恶化(OR=0.26,p<0.01)及面神经(OR=1.62,p<0.01)和三叉神经(OR=1.42,p=0.07)损伤增加相关。

要点

  • 16项研究共589例患者750个肿瘤,临床肿瘤控制率88%(95%CI 80-95%)。
  • 需挽救手术者占8%(95%CI 4-13%)。
  • 治疗与可服务听力恶化(OR=0.26,p<0.01)、面神经损伤增加(OR=1.62,p<0.01)相关。

核心结论

  • 当前立体定向放射外科方案虽实现高肿瘤控制,但导致听力受损和更差颅神经合并症,尚不清楚这些发现应视为治疗并发症还是疾病持续进展。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid MEDLINE、EMBASE、Web of Science和Cochrane Reviews,纳入仅评估2型神经纤维瘤病相关前庭神经鞘瘤立体定向放射外科结局的研究,共16项研究(589例患者、750个肿瘤)。

主要发现

  • 临床肿瘤控制率达88%(95%CI 80-95%)。
  • 需挽救手术者占8%(95%CI 4-13%)。
  • 治疗与既往可服务听力恶化相关(OR=0.26,p<0.01)。
  • 治疗与面神经损伤增加相关(OR=1.62,p<0.01)。
  • 治疗与三叉神经损伤相关(OR=1.42,p=0.07)。

局限性

  • 前庭症状和脑积水发生率报告不一致,无法评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Neurofibromatosis type 2 (NF2) is characterized by often bilateral vestibular schwannomas (VS) that result in progressive hearing loss and compression of nearby brainstem structures causing cranial nerve palsies. Treatment of these tumors remains challenging, as both surgical removal and expectant management can result in symptom progression. Stereotactic radiosurgery (SRS) has been investigated for the management of NF2-associated VS; however, the role, promises, and pitfalls of this treatment modality remain unclear. METHODS: Ovid MEDLINE, EMBASE, Web of Science, and Cochrane Reviews were searched for studies assessing SRS outcome in NF2-associated VS only. Primary endpoints included tumor control, serviceable hearing, presence of tinnitus, and cranial nerve V and VII symptoms. RESULTS: A total of 16 studies (589 patients harboring 750 tumors) were analyzed. Clinical tumor control was achieved in 88% of cases (95% CI 80-95%); salvage surgery was needed in 8% (95% CI 4-13%) of cases. Treatment resulted in a worsening of pre-treatment serviceable hearing (OR = 0.26, p < 0.01), increased facial nerve (OR = 1.62, p < 0.01) and trigeminal nerve (OR = 1.42, p = 0.07) impairment. The incidence of vestibular symptoms and hydrocephalus were not consistently reported and thus could not be assessed. CONCLUSIONS: The treatment of NF2-associated VS continues to pose a challenge, as current SRS regimens result in impaired hearing and worse cranial nerve comorbidities, despite achieving high tumor control. It remains unclear if these findings have to be regarded as treatment complications or, rather, continued disease progression.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Tosi U, Maayan O, An A, et al. Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis. J Neurooncol. 2022. PMID: 35040021. doi:10.1007/s11060-021-03910-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。